Cargando…

Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases

The complex network of malfunctioning pathways occurring in the pathogenesis of neurodegenerative diseases (NDDs) represents a huge hurdle in the development of new effective drugs to be used in therapy. In this context, redox reactions act as crucial regulators in the maintenance of neuronal microe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bacci, Andrea, Runfola, Massimiliano, Sestito, Simona, Rapposelli, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997428/ https://www.ncbi.nlm.nih.gov/pubmed/33671015 http://dx.doi.org/10.3390/antiox10030367

Ejemplares similares

Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders
por: Saponaro, Federica, et al.
Publicado: (2020)

Design, Synthesis, and In Vitro Evaluation of Novel 8-Amino-Quinoline Combined with Natural Antioxidant Acids
por: Bacci, Andrea, et al.
Publicado: (2022)

SUN-717 SG-2 a Novel Multi-Target Directed Ligand (MTDL) for the Treatment of Neurodegenerative Diseases (NDDS)
por: Sestito, Simona, et al.
Publicado: (2020)

New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective
por: Sestito, Simona, et al.
Publicado: (2018)

Collecting data through high throughput in vitro early toxicity and off-target liability assays to rapidly identify limitations of novel thyromimetics
por: Runfola, Massimiliano, et al.
Publicado: (2020)

Potential role of two novel agonists of thyroid hormone receptor‐β on liver regeneration
por: Perra, Andrea, et al.
Publicado: (2020)

TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD
por: Caddeo, Andrea, et al.
Publicado: (2021)

Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-Like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents through the Modulation of SIRT6
por: Bellusci, Lorenza, et al.
Publicado: (2020)

Hydrogen Sulfide: A Worthwhile Tool in the Design of New Multitarget Drugs
por: Sestito, Simona, et al.
Publicado: (2017)

Memantine prodrug as a new agent for Alzheimer’s Disease
por: Sestito, Simona, et al.
Publicado: (2019)

Synthetic Thyroid Hormone Receptor-β Agonists Promote Oligodendrocyte Precursor Cell Differentiation in the Presence of Inflammatory Challenges
por: Baldassarro, Vito Antonio, et al.
Publicado: (2023)

Epibatidine: A Promising Natural Alkaloid in Health
por: Salehi, Bahare, et al.
Publicado: (2018)

Natural Compounds as Beneficial Antioxidant Agents in Neurodegenerative Disorders: A Focus on Alzheimer’s Disease
por: Amato, Antonella, et al.
Publicado: (2019)

Diphenyl-Methane Based Thyromimetic Inhibitors for Transthyretin Amyloidosis
por: Kim, Bokyung, et al.
Publicado: (2021)

Antioxidant Therapeutic Strategies in Neurodegenerative Diseases
por: Morén, Constanza, et al.
Publicado: (2022)

Dual PDK1/Aurora Kinase A Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony Formation
por: Casari, Ilaria, et al.
Publicado: (2019)

Synthesis and Functional Evaluation of Novel Aldose Reductase Inhibitors Bearing a Spirobenzopyran Scaffold
por: Digiacomo, Maria, et al.
Publicado: (2017)

Ozone: a natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disorders
por: Scassellati, Catia, et al.
Publicado: (2020)

New Synthetic Methodology for Drug-like Molecules
por: Barker, Graeme, et al.
Publicado: (2023)

Editorial: New insights into the mechanisms of resistance to anti-cancer drugs
por: Bertoni, Francesco, et al.
Publicado: (2022)

Natural Bioactive Products with Antioxidant Properties Useful in Neurodegenerative Diseases
por: Mendonça-Junior, Francisco J. B., et al.
Publicado: (2019)

Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease
por: Runfola, Massimiliano, et al.
Publicado: (2021)

New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection
por: Bellusci, Lorenza, et al.
Publicado: (2017)

Multi sequence average templates for aging and neurodegenerative disease populations
por: Dadar, Mahsa, et al.
Publicado: (2022)

Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells
por: Daniele, Simona, et al.
Publicado: (2015)

Natural Bioactive Products with Antioxidant Properties Useful in Neurodegenerative Diseases 2020
por: Mendonça-Junior, Francisco Jaime Bezerra, et al.
Publicado: (2021)

Natural Antioxidant Compounds as Potential Pharmaceutical Tools against Neurodegenerative Diseases
por: Marino, Attilio, et al.
Publicado: (2022)

Autoimmune Aspects of Neurodegenerative and Psychiatric Diseases: A Template for Innovative Therapy
por: de Haan, Peter, et al.
Publicado: (2017)

Induced pluripotent stem cell-derived and directly reprogrammed neurons to study neurodegenerative diseases: The impact of aging signatures
por: Aversano, Simona, et al.
Publicado: (2022)

The Potential for Natural Antioxidant Supplementation in the Early Stages of Neurodegenerative Disorders
por: Oppedisano, Francesca, et al.
Publicado: (2020)

The involvement of microRNAs in neurodegenerative diseases
por: Maciotta, Simona, et al.
Publicado: (2013)

Frontier in Neurology Research Beyond Neurodegenerative Diseases
por: Le, Wei-Dong
Publicado: (2015)

Polyglutamine diseases: looking beyond the neurodegenerative universe
por: Mielcarek, Michal, et al.
Publicado: (2020)

Targeting Protein Aggregates with Natural Products: An Optional Strategy for Neurodegenerative Diseases
por: Xiang, Lingzhi, et al.
Publicado: (2023)

Natural Immunity to HIV: A Template for Vaccine Strategies
por: Fourcade, Lyvia, et al.
Publicado: (2018)

Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis
por: Caddeo, Andrea, et al.
Publicado: (2023)

Editorial: Prion and prion-like proteins in neurodegenerative diseases
por: Toni, Mattia, et al.
Publicado: (2022)

Role of Natural Antioxidants from Functional Foods in Neurodegenerative and Metabolic Disorders
por: Carvalho, José C. T., et al.
Publicado: (2018)

Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer
por: Emmanouilidi, Aikaterini, et al.
Publicado: (2019)

3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
por: Rutigliano, Grazia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_toi4eclt2pvil9i0suid6dcs9a